4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2020

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis

(1) , (1) , (1, 2) , (1) , (1) , (1) , (3) , (4, 3, 5) , (6) , (7) , (8) , (9) , (9) , (7) , (1)
1
2
3
4
5
6
7
8
9
Astrid Musnier
  • Function : Author
Valérie Gouilleux-Gruart
Herve Watier

Abstract

Granulomatosis with polyangiitis (GPA) is a severe autoimmune vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA) mainly targeting proteinase 3 (PR3), a neutrophilic serine proteinase.PR3-ANCA binding to membrane-bound PR3 on neutrophils induce their auto-immune activation responsible for vascular lesions. However, the correlation between PR3-ANCA level and disease activity remains inconsistent, suggesting the existence of non-pathogenic PR3-ANCA. In order to prove their existence, we immortalized B lymphocytes from blood samples of GPA patients in remission having persistent PR3-ANCA to isolate non-activating PR3-ANCA. We obtained for the first time a non-activating human IgG1κanti-PR3 monoclonal antibody (mAb) named 4C3. This new mAb binds soluble PR3 with a high affinity and membrane-bound PR3 on an epitope close to the PR3 hydrophobic patch and in the vicinity of the active site. 4C3 is able to bind FcγRIIA and FcγRIIIB and has a G2F glycosylation profile on asparagine 297. 4C3 did not induce activation of neutrophils and could inhibit human polyclonal PR3-ANCA-induced activation suggesting that 4C3 is non-pathogenic This characteristic relies on the recognized epitope on PR3 rather than to the Fc portion properties. The existence of non-pathogenic PR3-ANCA, which do not activate neutrophils, could explain the persistence of high PR3-ANCA levels in some GPA patients in remission and why PR3-ANCA would not predict relapse. Finally, these results offer promising perspectives particularly regarding the understanding of PR3-ANCA pathogenicity and the development of new diagnostic and therapeutic strategies in GPA
Fichier principal
Vignette du fichier
granel2020.pdf (3.71 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03039822 , version 1 (04-12-2020)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Jérôme Granel, Roxane Lemoine, Eric Morello, Yann Gallais, Julie Mariot, et al.. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis. Frontiers in Immunology, 2020, 11, 17 p. ⟨10.3389/fimmu.2020.573040⟩. ⟨hal-03039822⟩
96 View
74 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More